Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in median ages at death from selected cancer types in relation to HLA-DRB1/DQB1.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2014

An Wan-Xin, Fan Ya-Xin, Liang Xiao-Hua, Liu Hui

Abstract excerpt

The median ages at death from cancers between 1985 and 2005 were calculated to demonstrate that inherent anticancer mechanisms may be a common pathway for different cancers. Seventy-eight patients with gastric, liver and lung cancers, were recruited in the solid cancer group. The leukemia group c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Gene Frequency
Share to HLA-DQ beta-Chains

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-DRB1 Chains

Share to Leukemia

Share to Liver Neoplasms

Share to Lung Neoplasms

Share to Stomach Neoplasms

Source

Identifiers

PMID: 24935357
DOI: 10.7314/apjcp.2014.15.10.4125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24935357-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Changes in median ages at death from selected cancer types in relation to HLA-DRB1/DQB1.PMID 24935357Read ↗

Association between germ-line HLA and immune-related adverse eventsSemantic proximity Read ↗

Association between HLA-DRB1*04:05 and the efficacy of immune checkpoint inhibitors for patients with advanced cancer.Semantic proximity Read ↗

Long-term Hematopoietic Transfer of the Anti-Cancer and Lifespan-Extending Capabilities of A Genetically Engineered Blood System by Transplantation of Bone Marrow Mononuclear CellsSemantic proximity Read ↗

Genetic risk analysis for an individual according to the theory of programmed onset, illustrated by lung and liver cancers.Semantic proximity Read ↗

Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt.Semantic proximity Read ↗

HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer.Semantic proximity Read ↗

Association of DR4 (TRAIL-R1) polymorphisms with cancer risk in Caucasians: an updated meta-analysis.Semantic proximity Read ↗

Association between HLA-DQA1, HLA-DQB1 and oral cancer.Semantic proximity Read ↗

Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.